Status: current, Defined. Date: 31-Jan 2011. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3338811000168118 | cetalkonium chloride 100 microgram / 1 g + choline salicylate 87 mg / 1 g + menthol 570 microgram / 1 g gel (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3340191000168116 | choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | has manufactured dose form | gel | true | Inferred relationship | Some | ||
| choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | Is a | choline salicylate 8.7% gel | true | Inferred relationship | Some | ||
| choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | Is a | salicylic acid + menthol + cetalkonium chloride | true | Inferred relationship | Some | ||
| choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | has intended active ingredient | menthol | true | Inferred relationship | Some | 1536600580 | |
| choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | has Australian BoSS | menthol | true | Inferred relationship | Some | 1536600580 | |
| choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | has intended active ingredient | cetalkonium chloride | true | Inferred relationship | Some | 782685874 | |
| choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | has Australian BoSS | cetalkonium chloride | true | Inferred relationship | Some | 782685874 | |
| choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | has intended active ingredient | salicylic acid | true | Inferred relationship | Some | 1346916366 | |
| choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | has Australian BoSS | choline salicylate | true | Inferred relationship | Some | 1346916366 | |
| choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | has manufactured dose form | oral gel | false | Inferred relationship | Some | ||
| choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | has unit of use | continuous | true | Inferred relationship | Some | 1536600581 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel, 15 g | has MPUU | True | choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | Inferred relationship | Some | 1 |
| Sedagel gel | Is a | True | choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | Inferred relationship | Some | |
| choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel, 30 g | has MPUU | True | choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% gel | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR